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ABSTRACT Cytopathic effects (CPEs) are a hallmark of infections. CPEs are difﬁcult
to observe due to phototoxicity from classical light microscopy. We report distinct
patterns of virus infections in live cells using digital holo-tomographic microscopy
(DHTM). DHTM is label-free and records the phase shift of low-energy light passing
through the specimen on a transparent surface with minimal perturbation. DHTM
measures the refractive index (RI) and computes the refractive index gradient (RIG),
unveiling optical heterogeneity in cells. We ﬁnd that vaccinia virus (VACV), herpes
simplex virus (HSV), and rhinovirus (RV) infections progressively and distinctly in-
creased RIG. VACV infection, but not HSV and RV infections, induced oscillations of
cell volume, while all three viruses altered cytoplasmic membrane dynamics and in-
duced apoptotic features akin to those caused by the chemical compound stauro-
sporine. In sum, we introduce DHTM for quantitative label-free microscopy in infec-
tion research and uncover virus type-speciﬁc changes and CPE in living cells with
minimal interference.
IMPORTANCE This study introduces label-free digital holo-tomographic microscopy
(DHTM) and refractive index gradient (RIG) measurements of live, virus-infected cells.
We use DHTM to describe virus type-speciﬁc cytopathic effects, including cyclic vol-
ume changes of vaccinia virus infections, and cytoplasmic condensations in herpes-
virus and rhinovirus infections, distinct from apoptotic cells. This work shows for the
ﬁrst time that DHTM is suitable to observe virus-infected cells and distinguishes virus
type-speciﬁc signatures under noninvasive conditions. It provides a basis for future
studies, where correlative ﬂuorescence microscopy of cell and virus structures anno-
tate distinct RIG values derived from DHTM.
KEYWORDS apoptosis, cell contraction, cell volume, herpes simplex virus, label-free
microscopy, live-cell microscopy, membrane blebbing, refractive index, rhinovirus,
tomography, vaccinia virus, virus infection
Viruses have a dual nature, the particle and the infected cell. At the onset of aninfection, the particle introduces proteins, DNA or RNA, and sometimes lipids into
the host cell. The infected cell either produces viral components that are encoded in
the viral genome or raises an immune reaction against the virus and silences the
infection. In the former case, the infected cell develops a cytopathic effect (CPE). CPEs
are diagnostic hallmarks of a particular virus, and it is well-known that CPEs occur in cell
cultures (for reviews, see references 1 and 2). CPE can predict clinical outcomes in vivo.
Examples include exacerbation of steatosis by hepatitis C virus, apoptosis in trigeminal
ganglia by herpes simplex virus (HSV), or aseptic meningitis, paralysis, cardiomyelitis,
and herpangina by enteroviruses, including poliovirus, coxsackievirus, and enterovirus
(EV) type 71 (3–5). While virus-induced CPE and cell death are exacerbated by cytokine
responses, cytotoxic T cells, or natural killer (NK) cells, virus-induced CPE of cultured
cells apparently proceeds in a cell-autonomous manner.
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The nature and the extent of CPE depend on the virus, cell type, host innate
response, and progression of infection. For example, distinct levels of CPE correlate with
the amounts of newly synthesized virus particles (6). In adenovirus-infected cells, the
cells may lyse and release large amounts of viral particles after the cells show strong
CPEs, while persistently infected cells produce small amounts of progeny over time
(long term) and have weak CPEs (7, 8). Yet, the extent of CPE does not always correlate
with virion production, as cells undergoing programmed cell death feature strong CPE
at low viral titers (9–11). As viruses hijack cellular resources, CPEs elicited by virus
infection may have distinct features, such as loss of membrane integrity, cell shrinkage,
increased chromatin density, cell detachment from the substratum, formation of syn-
cytia, loss or enforcement of the cytoskeleton, and reorganization of intracellular
membranes (2, 12, 13). Despite the predictive nature of CPE for clinical and biological
infections, time-resolved 3D analyses of virus-induced CPE are missing.
Here we describe a new approach using 3D digital holo-tomographic microscopy
(DHTM) to study the CPEs induced by three different viruses: vaccina virus (VACV), a
large DNA virus replicating in the cytoplasm, herpes simplex virus type 1 (HSV-1), a
large DNA virus replicating in the nucleus, and rhinovirus (RV), a small RNA virus
replicating on cytoplasmic membranes. Classical video-enhanced contrast optical mi-
croscopy, such as interference microscopy and bright-ﬁeld microscopy, are limited by
uneven image ﬁeld intensity, lack of tomographic information, and a focus-dependent
size inﬂation of structures due to diffraction limitation (14). In contrast, DHTM allows
prolonged quantitative time-resolved 3D image acquisition using an ultralow-powered
laser (520-nm class 1 with 0.2 mW/mm2) without recognizable phototoxicity at high
temporal and spatial resolution (15).
RESULTS
We infected HeLa cells with the VACV strain Western Reserve harboring an early/late
GFP expressed transgene (VACV_WR E/L-GFP [VACV-GFP]) at a multiplicity of infection
(MOI) of 2, yielding 95% infected cells, ﬁxed the cells 8 h postinfection (pi) with
paraformaldehyde, and recorded the refractive index (RI), nuclear DAPI stain, and GFP
intensity by correlative DHTM and ﬂuorescence microscopy and compared the infected
cells to noninfected cells. At 8 h pi, all cells inoculated with VACV-GFP were infected
based on their GFP intensity and DAPI staining of cell nuclei, whereas the GFP intensity
of the uninfected cells was in the range of the background (Fig. 1A). Based on the RI
change across a volume, the RI gradient (RIG) can be computed across the whole cell,
similar to the RIG across an index gradient lens (for a simplistic illustration, see Fig. 1B
and C).
We next imaged VACV-GFP-infected and uninfected cells in live-cell mode by DHTM
in 2-h intervals for up to 8 h pi (Fig. 2A). For each condition, two dishes were infected
as described in Materials and Methods. At least ﬁve randomly chosen cells from each
dish were imaged, yielding at least 10 cells per time point and condition. A progressive
and prominent change in RI was observed in the infected cells, visualized in scaled
pseudocolor. In contrast, the uninfected cells and the VACV-GFP-infected cells treated
with the deoxynucleoside analogue cytarabine (AraC), an inhibitor of VACV late gene
expression (16, 17), showed less prominent RI changes, although AraC-treated cells
inoculated with VACV-GFP exhibited a strong increase in RI in the cell nucleus. We
quantiﬁed the RI change by deriving the RIG values across the entire cell (Fig. 2B), as
described in Materials and Methods. The RIG values of the VACV-GFP-infected cells
gradually increased as the infection progressed, reaching threefold at 8 h pi compared
to the RIG prior to infection. In contrast, the RIG values of uninfected cells remained
largely constant over 8 h. The AraC-treated cells showed only a small RIG increase of
about 1.3-fold, suggesting that the RIG increase is predominantly due to viral late gene
expression. VACV infections exhibit membrane blebbing phenotypes at early and late
time points, as well as focal bud-like swellings (18). Such features are diagnostic of a
contractile cell cortex, as reported for uninfected cells in cell migration and response to
mechanical cues (19). We noticed an increased fraction of blebbing cells over 2 to 8 h
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pi in the presence of AraC (Fig. 2C). This is distinct from membrane blebbing during
entry (20) and suggests that blebbing at 8 h pi does not require viral late gene
expression and does not affect the RIG.
To test whether similar morphology changes of the VACV-GFP-infected cells can be
observed with an alternative imaging modality, we infected HeLa cells with VACV-GFP
at an MOI of 2 and imaged live cells in phase-contrast and ﬂuorescence modes at 5-min
FIG 1 Correlative digital holo-tomographic microscopy and light microscopy of ﬁxed and permeabilized
cells. (A) Representative images of HeLa-ATCC cells incubated with 2 ml RPMI at 37°C for 8 h, ﬁxed in 4%
PFA in PBS, and imaged with a DHTM microscope and an attached epiﬂuorescence module. The cells
were either infected with VACV expressing GFP under the control of early/late promoters (VACV_E/L-GFP;
top and middle panels) at an MOI of 2 or left uninfected (bottom panel). The top panels depict a
VACV-GFP-infected cell in early infection stage. The middle panels depict a rounding cell, indicating
late-stage VACV infection. The bottom panel depicts an uninfected cell. RI is displayed in gray, GFP is
shown in green, and nuclei stained with DAPI appear in blue. Bar, 20 m. (B) Schematic illustrations of
RI computation. A cell can be thought of as a gradient index microlens, changing its optical properties
depending on biochemical activities. (C) RIG is derived from RI and represents a voxel-based measure-
ment of the difference of the refractive index in 3D space. The RIG value of the voxel in the middle is
represented as a middle blue box, which is calculated based on the difference to the light blue voxels
in the 3D neighborhood. Note that the reference beam (curved green dashed line) does not pass through
the sample. RI is based on changes between the beam (straight green dashed line) and the reference
beam.
Live Holo-Tomography in HSV, VACV, and RV Infections
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intervals for 8 h (Fig. 3; see also Video S1 in the supplemental material) by using a
high-throughput light microscope. In agreement with the DHTM imaging results, the
VACV-GFP-infected cells expressed the GFP transgene at increasing intensity over the
course of infection. As recorded in the DHTM experiments, we observed host cell
rounding, contractions and late stage blebbing of the infected cells, while the features
of the uninfected cells remained largely invariant.
We next investigated the dynamic properties of the VACV-GFP-infected cells by
using the holographic information, including cell volume. We reasoned that a change
in cell volume might result in changes in the density of the cytoplasm, and hence affect
the refractive properties of the cell. The accuracy of volumetric measurements based on
DHTM was ﬁrst assessed with polystyrene beads of different nominal sizes ranging from
0.5 to 4 m (Fig. 4A). Bead size was determined by two different analysis methods, a
pixel-based method using the vendor’s software, STEVE, and an object-based 3D-
surface segmentation method using Imaris (Fig. 4B). Both procedures yielded similar
results, although the object-based method was slightly more accurate.
To measure cell volume by DHTM, we used the image stack segmentation proce-
dure in Imaris. Time-resolved 3D live-cell DHTM imaging of infected and uninfected
FIG 2 VACV late gene expression increases the cellular RIG. (A) Representative images of HeLa-ATCC cells incubated with 2 ml
RPMI at 37°C for 8 h and imaged at 2-h intervals by DHTM. Cells were uninfected, infected with VACV-GFP at an MOI of 2, or
infected with VACV-GFP at an MOI of 2 in the presence of 10 M AraC. The perimeters of the cells grown on coverslips are
outlined with white dashed lines. RIs are depicted as intensity values in a “thermal” lookup table. Images were obtained as
holograms and depicted as projections of maxima along the z axis of the 3D stacks. Bar, 20 m. (B) Cell RIG quantiﬁcation of
panel A. RIG values were normalized to 1 for 0 h postinfection (pi). Bars depict mean values plus SEM (error bars) of at least
10 cells for each condition and time point. (C) Comparison of the frequency of the “blebbing” phenotype in VACV-GFP-infected
cells and VACV-GFP-infected cells in RPMI containing 10 M AraC. Data from at least 10 cells per time point and condition were
acquired and manually scored as blebbing or nonblebbing.
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cells between 0 and 8 h pi indicated that the VACV-GFP-infected cells underwent a
series of shrinkage and dilation phases, while the volume of the uninfected cells
remained largely constant (Fig. 5, Video S2, and Video S3). The ﬁrst shrinkage phase
peaked at about 100 min pi and reduced the cell volume by about 50%. This contrac-
tion was followed by a steady recovery phase restoring the original volume at about
180 min pi. The next shrinkage period started at 230 min and lasted about 40 min,
followed by a short recovery phase of about 30 min, and a period of stable volume with
minor ﬂuctuations until 440 min pi, when another shrinkage period occurred. We did
not detect a correlation between cell shrinkage or expansion with the RIG values, the
latter steadily increasing over the course of infection. We conclude that the VACV-GFP
infection-induced RIG increase is not caused by generic changes in cell volume.
To further explore the correlations of RIG and virus-induced CPE, we recorded RIG in
cells infected with HSV-1-GFP harboring a GFP transgene under the constitutively active
CMV promoter, and RV-A1a at 0, 8, 10, 12, 14, and 16 h pi (Fig. 6A). Calculations are
based on at least 10 cells per time point and condition. In HSV-1-GFP-infected cells, CPE
was observed from 8 to 10 h pi on, followed by cell surface roughening at 16 h pi.
Remarkably, RIG did not increase despite the onset of CPE prior to 16 h pi (Fig. 6B). Cells
infected with RV-A1a showed strong CPE starting from 10 and 12 h pi, involving the
condensation of cytoplasm. The RIG of RV-A1a-infected cells steadily increased at 10 to
16 h pi up to about 2.5-fold of the RIG of the uninfected controls. The RIG increase
occurred during a time frame when apoptosis, virus-controlled necroptosis, and the
loss of cytoskeletal elements, such as F-actin, take place (21–23). Remarkably, RV-A1a-
infected cells adopted a transient branched shape at 12 to 14 h pi, before rounding up
at 16 h pi (Fig. 6A).
Two distinct inhibitors of RV replication were employed to test whether the RIG
FIG 3 Cell morphology and VACV-GFP transgene expression visualized by automated and correlative
phase-contrast and ﬂuorescence live-cell time-lapse microscopy. HeLa-ATCC cells were uninfected (left
panels) or infected (right panels) with VACV-GFP using the cold binding protocol (30-min inoculation on
ice, wash, and transfer to 37°C). Cells were imaged with a high-throughput wide-ﬁeld microscope every
5 min for 8 h. Cells were visualized with transmission light, the GFP ﬂuorescence was intensity color
coded (color bar ranging from transparent through blue to white). Bars, 50 m. See also Video S1 in the
supplemental material.
Live Holo-Tomography in HSV, VACV, and RV Infections
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increase was directly associated with RV-A1a replication. The ﬁrst inhibitor, PIK-93,
blocks phosphatidylinositol-4-kinase class 3beta (PI4K3b) activity, and thereby pre-
cludes the lipid remodeling by countercurrent lipid ﬂuxes for virus replication (24). In
the absence of PI4K3b activity, viral replication is suppressed, because the altered lipid
composition of the replication membrane can no longer support viral host proteins
necessary for virus replication (reviewed in reference 25). The second inhibitor,
MLN9708, is a second-generation inhibitor of the proteasome, which is required for
enterovirus replication (26–28). Both PIK-93 and MLN9807 blocked the appearance of
high-RI/RIG structures, although the effect of PIK-93 was incomplete (Fig. 7). The partial
effect of PIK-93 on RIG was, however, consistent with the partial reduction of PI4P levels
and the incomplete inhibition of RV-A1a replication (24, 29). These results support the
notion that an increase in RIG in virus-infected host cells occurs in a virus type-speciﬁc
manner and that RIG changes are a reliable indicator of early and late CPE. The latter
is often associated with virus-induced apoptosis, necrosis, or necroptosis. We therefore
tested whether the apoptosis-inducing agent staurosporine (30) also induced a RIG
response. DHTM tomography of cells treated with 10 M staurosporine (Fig. 8A)
conﬁrmed that staurosporine induces an apoptotic phenotype as early as 1 h after
treatment. Image quantiﬁcations indicated that RIG increased up to 4 h after applica-
FIG 4 Benchmarking the volume measurement using polystyrene beads of deﬁned size. (A) Polystyrene
beads (Tetraspeck; ThermoFisher) of deﬁned diameter were diluted in PBS, allowed to sediment to the
bottom of the dishes, and imaged using a 3D Cell Explorer microscope. The small colored boxes depict
digital RI stain of beads in red on black background. The large boxes show full 3D visualization of
acquired holographs. 3D stacks of the beads were digitally stained (voxel segmented) for an RI estimated
to cover at least 95% of the bead volumes. Bars, 5 m. (B) Comparison of volume quantiﬁcation
performed by voxel summation either by voxel segmentation and counting in STEVE software or by
surface ﬁtting in Imaris. Bead diameter was computed based on voxel counts and voxel size and
compared to the nominal diameter provided by the manufacturer.
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tion and slightly decreased at 5 h (Fig. 8B). The extent of the RIG increase reached levels
similar to the levels reached upon RV-A1a infection, thereby conﬁrming that apoptotic
phenotypes can be tracked by DHTM.
DISCUSSION
DHTM is a noninvasive label-free light microscopy technology. It measures the RI of
a transparent object by an interference procedure (31–36). DHTM is superior to classical
optical techniques, such as tomographic phase microscopy and diffraction phase
microscopy (37), because of its high sensitivity, accuracy, and noninvasiveness. The
system produces quantitative 3D information at high spatial and temporal resolution.
It readily measures the volume of cells and subcellular structures. Furthermore, it can
be used to acquire two new dimensions of cell data, RI and RIG, which cannot be readily
assessed by other imaging modalities. The methodology is robust and overcomes a
series of technical limitations in live-cell pathogen imaging, including the labeling of
cellular and viral entities by chemical or genetically encoded ﬂuorophores, and toxicity
ensuing imaging (for recent reviews, see references 38 and 39). The noninvasiveness
and low laser power required for DHTM underscore the suitability of DHTM for
long-term live imaging (40).
Here, we introduce DHTM to virus research by employing three different viruses,
VACV of the Poxviridae, HSV-1 of the Herpesviridae, and RV from the Picornaviridae.
VACV is an enveloped, double-stranded DNA virus, replicating and assembling particles
in the cytoplasm (41). It is used to immunize and protect humans against smallpox
caused by variola virus, one of the deadliest viruses to humans (42, 43). VACV exploits
apoptotic mimicry to enter host cells through cellular blebbing, that is, protrusions of
the cell membrane, implicated in cytokinesis and cell motility (20, 44, 45). VACV-
FIG 5 Cell morphology and volume dynamics of VACV-GFP-infected cells, visualized by label-free
time-lapse DHTM. HeLa-ATCC cells were infected by VACV-GFP following the cold binding protocol. Cell
holograms were acquired every minute for 8 h. RI is shown as gray scale images. Volume measurement
was performed using Imaris software by surface ﬁtting and 3D rendering (see the lower left corner of
each frame). The plots in the lower right-hand corners show the relative volume (in arbitrary units [a.u.])
normalized to 0 min pi. The red dashed lines correspond to the time points related to the corresponding
hologram. Bars, 20 m. See also Video S2 and Video S3 in the supplemental material.
Live Holo-Tomography in HSV, VACV, and RV Infections
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induced morphological changes of host cells include cell rounding, blebbing, and
bud-like swellings (18). Picornaviruses are small, positive-sense single-stranded RNA
viruses with a nonenveloped icosahedral capsid of 28 to 30 nm in diameter (46). RVs
replicate in the cytoplasm on Golgi-derived membranes that are closely associated with
the ER, and elicit a strong CPE in tissue culture (23–25). HSV-1 is an enveloped,
double-stranded DNA virus, well adapted to human hosts and controlled by innate
immunity, including the interferon-induced human myxovirus resistance protein B
(MxB) (47). If HSV-1 breaks through the innate host defense, it replicates in the cell
nucleus and sheds progeny prior to cell lysis (48, 49). In its latent state, HSV-1 evades
the immune system, avoids CPE, and downregulates apoptosis (50, 51). Upon reacti-
vation, HSV-1 is transmitted to the epidermal tissue where it causes lytic infection
manifested as epidermal blisters.
We initially used DHTM to determine the volume of cells and became aware of
periodic shrinkage and expansion of VACV-infected cells, as well as membrane bleb-
bing at late stages of VACV infections, but not in RV-A1a infections. The cyclic volume
changes observed by DHTM in VACV infections may be related to cellular contractility
changes observed previously in VACV-infected cells, including cell rounding early and
cell ﬂattening late in infection (52). In pathology, cell volume dysregulation contributes
to disorders, such as liver insufﬁciency, diabetic ketoacidosis, hypercatabolism, ﬁbrosing
disease, and sickle cell anemia, and regulation of cell volume affects cell proliferation
and apoptosis (53). The VACV infection-induced cell volume oscillation implies that
VACV regulates membrane trafﬁcking, such as endocytosis and secretion, and possibly
FIG 6 HSV-1 and RV increase cellular RIG late in infection. (A) Representative images of uninfected and infected cells imaged
by a DHTM microscope at the indicated time points. HeLa-ATCC cells were infected with HSV-1-GFP (MOI of 10), and HeLa Ohio
cells were infected with RV-A1a (MOI of 50). The perimeters of the cells grown on coverslips are outlined with white dashed
lines, and the refractive indices are depicted as intensities in a “thermal” lookup table. Images were obtained as holograms,
and the 3D stacks are depicted as z-projections of maxima. Bars, 20 m. (B) Normalized cell RIG of the data shown in panel
A. Bars depict mean values  SEM of at least 10 cells for each condition and time point.
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also ion channels. For example, the release of potassium, chloride, and bicarbonate ions
is known to trigger cell shrinkage, or the accumulation of sodium, potassium, and
chloride ions causes cell swelling through the activation of cotransporters, exchangers,
or channel proteins (53). In addition, shrinkage and swelling processes involve organic
osmolytes, such as sorbitol and glycerophosphorylcholine, which accumulate in shrink-
ing cells and are released in swelling cells. How exactly VACV controls these processes
remains an open question.
In addition to the accurate, noninvasive readout of cell volume, the RIGs measured
by DHTM have served as an indicator for the granularity of cell structures (54). We show
that speciﬁc RIG signatures indicate virus-induced CPEs. CPE follows cell shrinkage and
blebbing and terminates in cell death (12, 55). In fact, viruses control cell death
processes, including apoptosis or necroptosis, for example by diverting upstream
regulating kinases, such as RIPK1 in RV-infected cells (1, 23). Other viruses prevent
infection-induced apoptosis at early stages, gaining crucial time for production of virus
progeny (50, 56–58). At late infection stages, viruses gain virulence by enhancing
FIG 7 Drug treatment inhibits changes in RIs of RV-A1a-infected cells. Representative images of
mock-infected (top panel) or RV-A1a-infected (MOI of 50) HeLa Ohio cells (lower three panels). Cells were
treated with either PIK93 (5 M), or MLN9708 (10 M), and imaged by DHTM for 8 h at 1-min intervals.
Cell membranes are labeled in green, high RI and RIG regions are shown in red. Images in the left column
depict central z-slices of reconstructed holograms, and the images in the right column are 3D recon-
structions of the holograms. See also Videos S4 to S7. Bars, 10 m.
Live Holo-Tomography in HSV, VACV, and RV Infections
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progeny virus release from the cells (56, 59, 60). This leads to the notion that lytic
infection resembles a necrosis-like program, leading to the release of both cellular
contents and virus particles (7, 61).
CPEs are elicited not only by a wide range of pathogens, including viruses and
bacteria, but they also emerge in malignant cells during transformation and in immune
defense by cytotoxic cells for instance (6). Despite such insights, the CPE has remained
one of the least understood processes in infection biology and pathology. This is in part
due to the fact that a plethora of virus-induced cell reactions tune the infection,
including proviral and antiviral signaling and innate immunity response. CPE arises as
a result of the many altered processes in an infected cell. It is triggered by a few viral
genes introduced into a naive cell and comprises proviral and antiviral components.
Our results show that all viruses tested, VACV, HSV-1, and RV-A1a, induced RIG increase
over the course of infection, with virus-speciﬁc kinetics, extent, and signature. Impor-
tantly, the RIG measurements scored CPE independent of cell contractions and bleb-
bing, which cannot be uncoupled in phase-contrast microscopy. This indicates that RIG
truly measures new dimensions in CPE that have not been accessible with conventional
microscopy analyses. It underlines the superiority of DHTM over phase-contrast micros-
copy and allows the attribution of virus-speciﬁc processes to CPE. In the case of VACV
infection, the RIG increase appeared to require late viral gene expression, since RIG
changes were impaired by AraC, which inhibits late genes but not intermediate or early
genes. For RV, we infer that at the onset of RIG increase at 8 h pi, not only are
cytoplasmic membranes being rearranged and expanded for viral replication but also
phase separation processes occur in the perinuclear area, a hallmark of RV-infected
cells. In the case of HSV-1, the RIG increase was most dramatic at 16 h pi, with large
changes in the nucleus and the cytoplasm, indicative of processes associated with
virion production and release from the infected cell.
FIG 8 Staurosporine-induced apoptosis rapidly increases the cellular RIG. (A) Representative DHTM
images of HeLa-Ohio cells incubated with staurosporine (10 M) at 37°C for 5 h. Cell perimeters on the
glass coverslip are outlined with white dashed lines, and RIs are depicted as intensities in the “thermal”
lookup table. Images were obtained as holograms, and the 3D stacks are depicted as z-projections of
maxima. Bar, 20 m. (B) Cell RIG quantiﬁcation of panel A. RIG values were normalized to 1 at 0 h after
the addition. Bars depict mean values  SEM of at least 10 cells for each condition and time.
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In conclusion, we show that DHTM is suitable to analyze cell biological processes in
virus-infected cells at high spatiotemporal resolution, without the need to introduce
cell markers or use high-intensity laser light. DHTM has high spatial resolution with
potential superresolution options (35, 62). It enhances insights into CPE, a complex
phenotype induced by nearly all pathogens, and increasingly mined by high-
throughput screening assays (63). DHTM promotes the dynamic analyses of virus
assembly, for example in phase separated zones of the cytoplasm and the nucleus, and
provides a deeper understanding of the nature of viruses.
While the current state of DHTM technology has provided novel insights into
virus-host interactions, the current technology has some limitations. For example, the
correlative ﬂuorescence-RI images provided in Fig. 1 are still images acquired with a
prototype system and manual image acquisition. An automated stage would increase
the statistical power and enable analyses of cell-to-cell variability, for example in
correlation with virus replication kinetics and host factor contributions. Simultaneous
video acquisition and RI analyses would further facilitate a broad-scale assessment of
volume changes of whole cells or subcellular structures. Software implementations
allowing for noninvasive simultaneous imaging of multiple cells could enhance the
throughput of the technology. Collectively, this may enable future studies to test
scenarios, such as how the expression kinetics of viral genes affect RI and RIG or how
apoptosis and necrosis induction correlate with commonly used ﬂuorescence markers.
MATERIALS AND METHODS
Cell lines and viruses. HeLa-ATCC cells from the American Type Culture Collection (ATCC) were
maintained in Dulbecco modiﬁed Eagle medium (DMEM) (GIBCO-BRL) containing 10% fetal calf serum
(FCS), nonessential amino acids (NEAA), and penicillin-streptomycin (GIBCO-BRL) at 37°C and 5% CO2. All
cell cultures were maintained in a cell bank system and kept at low passage numbers for all experiments.
Vaccinia virus strain International Health Department J (VACV-IHD-J) containing early/late (E/L) GFP
transgene was kindly provided by J. Mercer (University College London, United Kingdom) (17, 64). To
obtain the puriﬁed mature virions (MVs), cytoplasmic lysates were pelleted through a 36% sucrose
cushion for 90 min with Optima XPN-100 ultracentrifuge (Beckmann Coulter) SW32Ti rotor at 18,000 rpm.
The viral pellet was suspended in 10 mM Tris (pH 9.0), and virus was separated from contaminating
material on a 25% to 40% sucrose gradient at 14,000 rpm for 45 min. Following centrifugation, the viral
band was collected by aspiration and concentrated by pelleting at 14,000 rpm for 45 min. MVs were
suspended in 1 mM Tris-HCl (pH 9.0), and the titers of virus were determined (titers in plaque-forming
units [PFU] per milliliter) as previously described (65).
RVs were grown in HeLa cells as described previously (66, 67). Cells were inoculated with a lysate
from infected cells at 33.5°C overnight. When CPE was visible in 80 to 90% of the cells, the medium was
removed, and cells were harvested by scraping and pelleting. Cells were lysed by three freeze/thaw
cycles in liquid nitrogen, followed by the addition of 1% NP-40 and homogenization with a Dounce
homogenizer. The suspension was centrifuged at 2,500 g for 10 min, and the supernatant was
transferred into a new tube. Free RNA was digested by the addition of 150 g RNase per 10 ml and
incubation at 37°C for 30 min. Virus was puriﬁed on a CsCl gradient and extensively dialyzed against
140 mM NaCl, 25 mM HEPES, and 5 mM MgCl2.
The HSV-1 recombinant strain C12 expressing GFP from the major CMV promoter was kindly
provided by S. Efstathiou (University of Cambridge, Cambridge, UK), and used as described previously
(47, 68). All virus stocks were stored at 80°C. Infectivity of virus stocks was quantiﬁed by high-
throughput ﬂuorescence microscopy to determine the amount of inoculum resulting in 95% infected
cells. From this, we calculated the MOI based on successful spreading events in plaque titration or TCID50
experiments. VACV was titered on HeLa-ATCC cells, RV on HeLa-OHIO, and HSV-1 on A549-ATCC cells,
according to earlier protocols (67). Virus-speciﬁc MOIs were calculated with TCID50s by the Reed-Muench
method (69). Note that VACV has an almost 1:1 ratio between early gene expression and spreading
infections, while RV has signiﬁcantly lower frequencies of virus spreading.
Cold-synchronized infections. Virus inocula were diluted into HEPES-buffered RPMI (Sigma) con-
taining 10% FCS, NEAA, and penicillin-streptomycin (GIBCO-BRL), added to HeLa cells, and incubated on
ice for 30 min. Enough virus was used to infect 95% cells in each of the DHTM experiments. Unbound
virus was washed off three times with cold phosphate-buffered saline (PBS) and overlaid with either 37°C
warm carbonate-buffered DMEM (GIBCO-BRL) containing 10% FCS, NEAA, and penicillin-streptomycin, or
warm HEPES-buffered RPMI (Sigma) containing 10% FCS, nonessential amino acids, and penicillin-
streptomycin for automated microscopy or tomographic holography, respectively.
Automated time-lapse, multisite, multichannel microscopy. Time-lapse, multisite, multichannel
microscopy on HeLa cells grown in 96-well imaging plates (Greiner Bio-One) was performed with an
ImageXpress Micro wide-ﬁeld high-content analysis system (IXM-XL; Molecular Devices) microscope with
a synthetic air-to-CO2 mixture of 95% to 5%, respectively, in a humidiﬁed environment at 37°C with a
20 objective.
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Live label-free holographic tomography. Live holographic tomography was performed using a 3D
Cell Explorer microscope (Nanolive SA, Ecublens, Switzerland). Cells were grown and imaged using
35-mm Ibidi glass bottom -Dish dishes (Ibidi GmbH, Germany). During imaging, temperature (37°C) and
humidity were controlled using an Ibidi Heating & Incubation System (Ibidi GmbH, Germany), while the
pH was maintained by using RPMI containing 20 mM HEPES buffer.
Cell tracking and volume measurement. To measure the cell volume, 3D stacks obtained by DHTM
were digitally stained and voxel segmented using STEVE (Nanolive SA, Ecublens, Switzerland), exported
as TIF ﬁles, and imported into Imaris (Bitplane AG, Switzerland). Next, a surface was ﬁtted to the imported
3D voxels aimed at complete volume segmentation. The ﬁtted surface was tracked and enclosed features
(volume, centroid position, and centroid speed) were measured with Imaris over the entire duration of
the time-lapse experiment. Finally, the volume of each cell in a time-lapse series was normalized to the
cell volume at time zero.
To benchmark the volume measurements from holographic tomography, we used polystyrene beads
with diameters of 0.5, 0.75, and 1 m (Fluoresbrite; Polysciences) and 4 m (Tetraspeck; ThermoFisher).
The beads were diluted in PBS, allowed to sediment to the bottom of the dish, and imaged. We next
quantiﬁed their volume either by voxel segmentation and counting in STEVE or by surface ﬁtting in
Imaris (Fig. 4).
Cell refractive index gradient measurement. The RI of a material is deﬁned as speed of light in
vacuum divided by the speed of light in the particular material. RIG is a computed value describing RI
change within a neighborhood of a particular voxel according to the following equation:
RIGRIx1,y,z RIx1,y,z2px 
2
 RIx,y1,z RIx,y1,z2py 
2
 RIx,y,z1 RIx,y,z12pz 
2
(1)
where 2px, 2py, and 2pz are the resolution of the image, and RIx1,y1,z1 is the RI value of the neighboring
pixels.
Measurement of the relative RIG of the cells was performed by “digital staining” in STEVE according
to the user manual. The staining was aimed at segmenting at least 95% of the manually determined
cellular signal; next, the mean RIG of the digital staining was calculated. Boundaries were adjusted by
shifting the RI outside of the 95% constraint. Finally, RIG of each cell in a time-lapse experiment was
normalized to the RIG of the cell at the start of the time-lapse experiment.
Data availability. Scripts, data, and further materials can be downloaded from the GitHub repository
at https://github.com/ayakimovich/DHMViruses.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphereDirect.00599-18.
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